Delivery Order SPE2DR25D3301-SPE2DR26F19HY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jardiance 25 mg tablets in a 90-count quantity. This competitively awarded, non-set-aside contract has a ceiling value of $54,079.52 with firm fixed pricing and is scheduled for completion by December 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $5,873.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $26,865.45. This firm fixed-price delivery order, which is not set-aside designated, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. The award represents a routine pharmaceutical procurement under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $13,245.31. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitively awarded, non-set-aside contract. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a firm fixed price ceiling value of $4,762.33 and completion targeted for November 26, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award to AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $17,047.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through AmerisourceBergen's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $2,351.60. This non-set-aside award is scheduled for completion by December 9, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $11,906.66. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a $47,507.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) to be delivered by September 10, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract was awarded on September 9, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $2,403.79. This non-set-aside delivery order employs firm fixed pricing and is scheduled for completion by December 2, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19HYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $34,482.99. This is a non-set-aside, competitively awarded delivery order to be completed by December 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC, designated SPE2DX, serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, including specialty medications, branded and generic drugs, and medical supplies across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.5k | 12/9/25 |